IN-DEPTH SYMPOSIA SESSION I

Evolving Concepts in the Management of Patients with Chronic Hyperthyroidism

4/26/2019
1:15 PM - 3:15 PM
Location: Convention Center 502 B

Presentations:

R. Mack Harrell, MD

Co-Director of the Memorial Center for Integrative Endocrine Surgery
Memorial Health System

Dr. R. Mack Harrell has built the last 27 years of his life around sound. In 1992, he became the first endocrinologist in the Cleveland Clinic system to bring neck ultrasound technology into the endocrine office setting. In 2011, he and his surgical partner, Dr. David Bimston established the first hospital-based integrative endocrine surgery office in the United States- bringing imaging endocrinologists and endocrine surgeons together with high resolution realtime ultrasound equipment and on site cytology capability to create a full service thyroidology, parathyroidolgy and adrenal practice serving Florida and the Caribbean. SInce 2005, Drs. Harrell and Bimston have published multiple peer-reviewed papers together regarding the diagnosis and treatment of thyroid nodular disease and hyperparathyroidism. Dr. Harrell has served as the president of AACE in 2014-2015 and the president of the American College of Endocrinology from 2017-2018. When not practicing thyroidology, Dr. Harrell enjoys working with sound in the range of human hearing and is an award winning member of the Nashville Songwriter's Association International (NSAI) in search of his first Country radio hit. Over the years he has been blessed to perform at AACE events with his bandmates Dr. Tim Bailey and Dr. Kathleen Figaro in the band "Sugar."

Presentation(s):

Send Email for R. Mack Harrell

Marius Stan, MD

Endocrinologist - Thyroid Core Group Chair
Mayo Clinic

Marius N. Stan, M.D., is a consultant in endocrinology at Mayo Clinic in Rochester, MN. He is Associate Professor in Medicine and is the current Chair of the Thyroid Core Group for the Division of Endocrinology at Mayo Clinic. He completed his endocrinology fellowship at Mayo Clinic Rochester and then obtained a Master degree in Clinical and Translational Research from Mayo Graduate School. Currently he combines clinical work with clinical research. He is primarily working in the area of autoimmune thyroid diseases, with a specific interest in Graves' disease and Graves' orbitopathy. He has been the PI or Co-investigator for a number of clinical trials targeting these disorders. He is also a member of the ATA Taskforce that generated the guidelines for evaluation and management of hyperthyroidism. Additional research interests relate to evaluation and management of thyroid nodules through radiofrequency ablation (RFA), understanding and management of thyroid dysfunction caused by amiodarone (amiodarone-induced thyrotoxicosis) as well as better understanding of the pathologies induced by other drugs that alter thyroid function. Dr. Stan's research aims to identify novel disease markers as well as new therapies for these conditions.

Presentation(s):

Send Email for Marius Stan

Sareh Parangi, MD

Professor of Surgery
Harvard Medical School Massachusetts General Hospital

Dr. Parangi is a busy endocrine surgeon at Massachusetts General Hospital (MGH), Harvard Medical School in Boston, with a particular interest and expertise in thyroid and parathyroid tumors. She focuses her clinical efforts on endocrine surgery and applies her basic science knowledge and expertise to tumor progression in thyroid cancer. She has been one of the Boston surgeons named in Best of Boston in Boston Magazine and her excellence in both research and her clinical expertise have earned her a national reputation. She serves as the Director of Diversity and Inclusion in the MGH Department of Surgery. Her other leadership roles include a seat on the MGH Executive Committee and as a member of the MGH Physician Organization Executive Committee where she is part of strategic planning and decision making at the highest levels of the organization. She is currently President of The Association of Women Surgeons (AWS) and Secretary of the International Thyroid Oncology Group. She has won numerous awards nationally and at Harvard Medical School for her NIH funded research in the role of BRAF oncoprotein in thyroid cancer invasion. Her active research focuses on understanding why some patients with thyroid cancer do worse than others and how to help them.

Presentation(s):

Send Email for Sareh Parangi

Gregory Randolph, MD FACS FACE

Claire and John Bertucci Chair in Thyroid Surgical Oncology Professor of Otolaryngology Head and Neck Surgery
Harvard Medical School

Gregory W. Randolph serves as Director of the General Otolaryngology Division and founded and directs the Division of Thyroid and Parathyroid Surgery. Dr. Randolph has a thyroid and parathyroid surgical practice seeing patients and operating at both Mass Eye and Ear Infirmary and Mass General Hospital.
Dr. Randolph has focused the bulk of his research on recurrent laryngeal nerve anatomy, preservation and monitoring during thyroid cancer surgery with focus on importance of laryngeal exam, recognition of lymph node metastasis and revision cancer surgery and has over 155 peer reviewed publications. He has lead thyroid surgical missions to thyroid surgical units in St. Petersburg, Russia, Guangzhou, China, Kenya, rural India and in the Chernobyl region of the Ukraine. He founded and directs the Harvard Thyroid and Parathyroid Surgery Course for surgeons and has directed international surgical courses in Italy, India, Germany, Switzerland and Russia. He has received board certification from the European Union’s Board of Surgery in Neck Endocrine Surgery. He has published an endocrine surgical text: “Surgery of the Thyroid and Parathyroid Glands” published by Elsevier Saunders now in its second edition as well as a text centered on surgery of the recurrent laryngeal nerve “The Recurrent and Superior Laryngeal Nerves” published by Springer Publishers. He was director of International Affairs for the American Academy of Otolaryngology Head and Neck Surgery served on their Board of Directors and currently is the Academy’s President. He has served as Treasurer and on the executive board of the American Thyroid Association. He currently serves as chair of the Endocrine Surgical Section of the American Head and Neck Society and is on the Board of Directors of the International Thyroid Oncology Group.

Presentation(s):

Send Email for Gregory Randolph


Assets

Evolving Concepts in the Management of Patients with Chronic Hyperthyroidism

Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Evolving Concepts in the Management of Patients with Chronic Hyperthyroidism